XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Accrued expenses and other current liabilities | 9 Months Ended
--- | ---
Sep. 30, 2018
Accrued expenses and other current liabilities |
Accrued expenses and other current liabilities | Note 9 — Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | September 30, |  | December 31, |
|  | 2018 |  | 2017 |
Accrued clinical and development expenditure |  | $ | 9,566 |  | $ | 10,065 |
Accrued employee expenses |  | 6,897 |  | 6,592 |
VAT |  | 3,388 |  | 5,741 |
Other accrued expenditure |  | 3,812 |  | 4,446 |
Other liabilities |  | 651 |  | 357 |
|  | $ | 24,314 |  | $ | 27,201 |
The Company typically has a receivable for VAT. As of December 31, 2017 and as of September 30, 2018, there was a VAT payable due to VAT arising on the milestone payments invoiced to GSK in 2017 and three months ended September 30,2018.

X
- References No definition available. + Details
Name: | adap_AccruedExpensesAndOtherCurrentLiabilitiesAbstract
Namespace Prefix: | adap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accrued expenses and other current liabilities at the end of the reporting period. + References No definition available. + Details
Name: | adap_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock
Namespace Prefix: | adap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration